Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Jaguar Health Inc (NQ: JAGX ) 1.270 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Jaguar Health Inc < Previous 1 2 ... 10 11 12 13 14 15 16 17 Next > Jaguar Health to Host Investor Webcast Monday, November 15th at 8:30 AM Eastern Time Regarding Q3 2021 Financials & Business Updates November 10, 2021 Click here to register for webcast Company plans to file Q3 2021 10-Q on November 15, 2021 SAN FRANCISCO, CA / ACCESSWIRE / November 10, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Jaguar Health's Italian Subsidiary Napo EU Appoints Annabella Amatulli Chief Regulatory Officer November 08, 2021 SAN FRANCISCO, CA / ACCESSWIRE / November 8, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced the appointment by Napo EU S.p.A., the company's Italian subsidiary, of Annabella Amatulli as chief... From Jaguar Health, Inc. Via AccessWire Exposures COVID-19 Product Safety Jaguar Health Completes Filing of New Animal Drug Application for Conditional Approval of Canalevia-CA1 (Crofelemer) to Treat Chemotherapy-Induced Diarrhea in Dogs, Clearing Way for December 2021 Launch November 02, 2021 Canalevia™-CA1 is the first and only oral plant-based prescription drug candidate for CID in dogs Jaguar kicks off educational awareness contest in honor of International Jaguar Day; Click here to... From Jaguar Health, Inc. Via AccessWire The Merger of Dragon SPAC S.p.A. and Napo EU S.p.A. has Closed November 01, 2021 The combined entity is named Napo EU S.p.A. SAN FRANCISCO, CA / ACCESSWIRE / November 1, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the merger of its Italian subsidiary Napo EU... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 29, 2021 SAN FRANCISCO, CA / ACCESSWIRE / October 29, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") announced today that, effective October 25, 2021, the Company granted nonstatutory... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety 12 Health Care Stocks Moving In Wednesday's Intraday Session October 27, 2021 Gainers Nurix Therapeutics (NASDAQ:NRIX) stock moved upwards by 15.4% to $33.42 during Wednesday's regular session. Trading volume for Nurix Therapeutics's stock... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session October 27, 2021 Gainers Bio-Path Holdings (NASDAQ:BPTH) shares moved upwards by 9.69% to $5.43 during Wednesday's pre-market session. The company's market cap stands at $37.7... Via Benzinga 64 Biggest Movers From Yesterday October 28, 2021 Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session October 25, 2021 Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 14.64% to $2.08 during Monday's regular session. The current volume of 7.2 million shares is 300.39% of Jaguar... Via Benzinga 60 Biggest Movers From Yesterday October 27, 2021 Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the... Via Benzinga Italian Government Clears Merger Plan of Dragon SPAC S.p.A. and Jaguar Health's Italian Subsidiary Napo EU S.p.A. for Closing October 25, 2021 Merger expected to be effective within a week The combined entity will be named Napo EU S.p.A. Merger effects the exclusive license agreement between Jaguar and Napo EU S.p.A. including up-front... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Jaguar Health Provides Updates on Crofelemer and Lechlemer Development Pipeline as well as Merger of Napo EU S.p.A. and Dragon SPAC S.p.A. October 07, 2021 Dragon SPAC and Jaguar subsidiary Napo EU submit required notification to the Italian government in support of consummating the merger Results accepted for third-party, investigator-initiated Phase 2... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Jaguar Health Earnings Perspective: Return On Capital Employed October 01, 2021 Jaguar Health (NASDAQ:JAGX) brought in sales totaling $385.00 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 32.1%, resulting in a loss... Via Benzinga Jaguar Health's Founder and CEO Lisa Conte to Be Honored with Pure Earth Impact Award September 30, 2021 Award celebrates Ms. Conte's 30-year, unrelenting commitment to supporting Indigenous communities in the Amazon and responsibly harvesting and commercializing the first-ever plant-based oral medicine... From Jaguar Health, Inc. Via AccessWire Topics Death Exposures Death Product Safety Jaguar Health Announces that Ladenburg Thalmann is Hosting R&D Showcase Webinar About Cancer Therapy-related Diarrhea on September 29, 2021 September 27, 2021 Leading oncologists discuss importance of supportive care for cancer patients to address debilitating diarrhea resulting from cancer therapy Virtual event 1:00 PM to 2:10 PM Eastern Registration open... From Jaguar Health, Inc. Via AccessWire Jaguar Health Receives "Complete" Letter from FDA for Last of Four Major Technical Sections for the Company's Application for Conditional Approval of Canalevia (Crofelemer) for Chemotherapy-Induced Diarrhea (CID) in Dogs September 23, 2021 Jaguar planning for launch of Canalevia™ for CID in dogs this December Canalevia is the first and only oral plant-based prescription drug candidate for CID in dogs SAN FRANCISCO, CA / ACCESSWIRE /... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety REMINDER: Jaguar Health to Host Investor Webcast Monday, September 20th at 8:30 AM Eastern Time September 16, 2021 Click here to register for webcast Jaguar kicks off educational awareness contest in honor of Indigenous Peoples' Day; Click here to enter SAN FRANCISCO, CA / ACCESSWIRE / September 16, 2021 / Jaguar... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Orphan Drug Designation Application Submitted by Jaguar Health Subsidiary for Crofelemer for Short Bowel Syndrome with Intestinal Failure Accepted for Review by European Medicines Agency September 15, 2021 The conditional marketing authorization pathway in Europe for crofelemer for this orphan disease is the initial focus of Napo EU under the license agreement between Napo EU and Napo Pharmaceuticals... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety 12 Health Care Stocks Moving In Tuesday's After-Market Session September 14, 2021 Gainers Xeris Pharmaceuticals (NASDAQ:XERS Via Benzinga Jaguar Health Announces Closing of Private Placement Priced at a Premium to Market September 14, 2021 Participating investors include Jaguar CEO and CFO, Dragon SPAC S.p.A. sponsor Josh Mailman, and plant-based pharmaceutical manufacturing pioneer Indena S.p.A. Company to host investor webcast Monday,... From Jaguar Health, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Product Safety Regulatory JAGX Stock: What Is Going on With Jaguar Health Today? September 09, 2021 Today, JAGX stock is surging higher on news of executive appointments, as well as the company's recent reverse stock split. Via InvestorPlace Jaguar Health Appoints Karen Brunke, Ph.D. as Corporate and Business Development EVP and Chip Whitlow as Animal Health Products Marketing Director September 09, 2021 Appointments represent Jaguar's focus on forging business development partnerships to advance crofelemer development and access and preparing for the expected near-term approval and commercialization... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Mid-Afternoon Market Update: Dow Falls Over 200 Points; RenovoRx Shares Spike Higher September 07, 2021 Toward the end of trading Tuesday, the Dow traded down 0.65% to 35,138.64 while the NASDAQ rose 0.13% to 15,383.18. The S&P also fell, dropping 0.27% to 4,522.99. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 72 Biggest Movers From Yesterday September 08, 2021 Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.... Via Benzinga Mid-Day Market Update: Gold Drops 2%; Pliant Therapeutics Shares Jump September 07, 2021 Midway through trading Tuesday, the Dow traded down 0.76% to 35,098.84 while the NASDAQ rose 0.09% to 15,376.87. The S&P also fell, dropping 0.33% to 4,520.38. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 45 Stocks Moving In Tuesday's Mid-Day Session September 07, 2021 Gainers IronNet, Inc. (NYSE: IRNT) shares jumped 50.4% to $25.06 after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares jumped 32.6% to $4.2443. The company recently... Via Benzinga 23 Stocks Moving in Tuesday's Pre-Market Session September 07, 2021 Gainers IronNet, Inc. (NYSE: IRNT) rose 89.7% to $31.61 in pre-market trading after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares rose 36.6% to $4.37 in pre-market... Via Benzinga Jaguar Health Stock Is Trading Lower In Reaction To Reverse Stock Split September 07, 2021 Jaguar Health Inc (NASDAQ: JAGX) will effect a reverse stock split of its issued and outstanding voting common stock at an exchange ratio of 1-for-3. The Company... Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session September 03, 2021 Gainers Enveric Biosciences (NASDAQ:ENVB... Via Benzinga Jaguar Health, Inc. Announces 1-for-3 Reverse Stock Split September 03, 2021 - Reverse split approved by majority of common stock shareholders at December 2020 special meeting of stockholders - Shares of Jaguar common stock to begin trading on split-adjusted basis on September... From Jaguar Health, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Product Safety Regulatory < Previous 1 2 ... 10 11 12 13 14 15 16 17 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.